Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 6547
The invention is directed to a method for assaying for Alzheimerâ€™s disease and to a method for treating the disease by modulating divalent or trivalent cation and/or heparin interaction in a patient with Amyloid Precusor Protein, or APP. The technologies or products that may arise from the invention include therapeutic agents such as zinc binding agents that modulate processing of APP, as well as a screening assay for Alzheimerâ€™s disease to determine the amount of various forms of APP in the circulatory system of a human compared to a control sample to determine presence of the disease.
IPSCIO Record ID: 7285
On September 10, 2007, we executed an Assignment and Novation Deed under which all rights and obligations under the patent assignment agreement were assigned.
The other patent entitled â€˜Method of Screening for inhibitors of Alzheimerâ€™s Disease,â€™ an Australian provisional application that matured into a patent application in the United States, was allowed to lapse in the second half of 2009.
IPSCIO Record ID: 5850
DEVELOPMENT PROGRAMS. means pharmaceutical, biotechnological and diagnostic development programs in the field of Alzheimer's Disease and other central nervous system and neurodegenerative diseases as performed by LICENSEE or its Affiliates.
LICENSED TECHNOLOGY. means (a) mice of the Tg 2576 strain of the transgenic mouse model described in Hsiao et al, Correlative Memory Deficils, A-Beta Elevation and Amyloid Plaques in Transgenic Mice, as published in Science on October 4, 1996, or in a U.S. continuation-in-part patent application, filed June 17, 1996, Serial No. 08/664,872 (the â€œCIP Applicationâ€), which mice are (1) progeny of a cross of a Tg2576 N2 male with a C57B6SJL female or (2) the progeny of a cross between (Tg2576 N2 x C57B6SJL) male with a C57B6SJL female, (such mice referred to herein asâ€ Stockâ€); (b) progeny of the Stock; and (c) certain transgenic mice that may result from the Sponsored Research Activities.